ORYZON to give updates on corporate progress in May

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give an update on corporate progress at several international events in May.

Oryzon will participate at the Swiss Biotech Day, which will be held on May 2-3 in Basel (Switzerland). During this event, Dr. Carlos Buesa, Oryzon’s CEO, will give an update on corporate progress on May 2 at 16:00 CEST. Dr. Buesa will also hold one-to-one meetings with pharmaceutical companies and global investors. Click on link for more info about the Swiss Biotech Day.

Oryzon will participate at the LSX World Congress, which will be held on May 10-11 in London (UK), where Dr. Buesa will give an update on corporate progress on May 10 at 15:15 local time. Dr. Buesa will also hold one-to-one meetings with pharmaceutical companies and global investors. Click on link for more info about the LSX World Congress

Oryzon will also participate at the BioEquity Europe conference, which will be held in Milan (Italy) and virtually on May 16-24. Dr. Buesa will present a corporate update and will also hold one-to-one meetings with pharmaceutical companies and global investors. Click on link for more info about the BioEquity Europe.

Oryzon has been invited to attend the H.C. Wainwright Global Investment Conference, which will be held in Miami (USA) and virtually on May 23-26. Dr. Saikat Nandi, Oryzon’s Global Chief Business Officer, will give an update on corporate progress and will also hold one-to-one meetings with pharmaceutical companies and global investors. Click on link for more info abou the H.C. Wainwright Global Investment Conference

Dr. Buesa will also participate at the PrecisionMed Expo & Summit, which will be held on May 24-25 in Dubai. Dr. Buesa will present a corporate update at the session on Genomic Profiling of Oncology Therapeutics on May 24 at 12:00 pm local time. Dr. Buesa will also hold one-to-one meetings with pharmaceutical companies and global investors. Click on link for more info about the PrecisionMed Expo & Summit.

Finally, Dr. Jordi Xaus, Oryzon’s CSO, and Dr. Enric Rello, Oryzon’s CFO, will attend the Foro MedCap BME, the major event for European investors and listed medium/small-cap companies in Spain, which will be held on May 24-26 in Madrid (Spain). Dr. Xaus and Dr. Rello will hold one-to-one meetings with national investors. Click on link for more info about the Foro MedCap BME.

More information on the attached file.